MB-107 Annamycin II Sarcoma
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Moleculin Biotech, Inc.
Start Date
March 3, 2021
End Date
April 1, 2024
Administered By
Institutes and Centers
Awarded By
Moleculin Biotech, Inc.
Start Date
March 3, 2021
End Date
April 1, 2024